153 related articles for article (PubMed ID: 30138657)
61. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
[TBL] [Abstract][Full Text] [Related]
62. Integrated transcriptomics and metabolomics reveal the mechanism of intestinal damage upon acute patulin exposure in mice.
Zhang T; Yan M; Chang M; Hou X; Wang F; Song W; Wang Y; Feng K; Yuan Y; Yue T
Ecotoxicol Environ Saf; 2024 May; 276():116270. PubMed ID: 38574645
[TBL] [Abstract][Full Text] [Related]
63. Prostaglandin E2 impairs osteogenic and facilitates adipogenic differentiation of human bone marrow stromal cells.
Noack C; Hempel U; Preissler C; Dieter P
Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():91-8. PubMed ID: 25512021
[TBL] [Abstract][Full Text] [Related]
64. The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
Li X; Yang B; Han G; Li W
J Oral Pathol Med; 2017 Nov; 46(10):991-997. PubMed ID: 28342204
[TBL] [Abstract][Full Text] [Related]
65. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases.
Lee J; Banu SK; Subbarao T; Starzinski-Powitz A; Arosh JA
Mol Cell Endocrinol; 2011 Jan; 332(1-2):306-13. PubMed ID: 21111772
[TBL] [Abstract][Full Text] [Related]
66. [Prostaglandin E2 promotes hepatocellular carcinoma cell proliferation through EP2 prostanoid receptor].
Guo D; Chen NN; Hou LB; Lei LS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1564-7. PubMed ID: 21945767
[TBL] [Abstract][Full Text] [Related]
67. COX-1/PGE
Peng X; Li J; Tan S; Xu M; Tao J; Jiang J; Liu H; Wu B
Sci Rep; 2017 Apr; 7(1):1055. PubMed ID: 28432343
[TBL] [Abstract][Full Text] [Related]
68. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.
Vukicevic S; Simic P; Borovecki F; Grgurevic L; Rogic D; Orlic I; Grasser WA; Thompson DD; Paralkar VM
Kidney Int; 2006 Sep; 70(6):1099-106. PubMed ID: 16871242
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats.
Gao JH; Wen SL; Tong H; Wang CH; Yang WJ; Tang SH; Yan ZP; Tai Y; Ye C; Liu R; Huang ZY; Tang YM; Yang JH; Tang CW
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G962-72. PubMed ID: 27056726
[TBL] [Abstract][Full Text] [Related]
70. COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins.
Bieniek J; Childress C; Swatski MD; Yang W
Prostate; 2014 Jul; 74(10):999-1011. PubMed ID: 24802614
[TBL] [Abstract][Full Text] [Related]
71. Study on Physiological Roles of Stimulation of Prostaglandin E2 Receptor Subtype EP2 in Urethral Function in Rats.
Kurihara R; Ishizu K; Takamatsu H; Yoshino T; Masuda N
Low Urin Tract Symptoms; 2016 May; 8(2):125-9. PubMed ID: 27111625
[TBL] [Abstract][Full Text] [Related]
72. Patulin induced ROS-dependent autophagic cell death in Human Hepatoma G2 cells.
Yang G; Bai Y; Wu X; Sun X; Sun M; Liu X; Yao X; Zhang C; Chu Q; Jiang L; Wang S
Chem Biol Interact; 2018 May; 288():24-31. PubMed ID: 29604266
[TBL] [Abstract][Full Text] [Related]
73. Potential therapeutic interventions via EP2/EP4 prostaglandin receptors.
Zimecki M
Postepy Hig Med Dosw (Online); 2012 May; 66():287-94. PubMed ID: 22706114
[TBL] [Abstract][Full Text] [Related]
74. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone promoted gastric cancer growth through prostaglandin E receptor (EP2 and EP4) in vivo and in vitro.
Shin VY; Jin HC; Ng EK; Cho CH; Leung WK; Sung JJ; Chu KM
Cancer Sci; 2011 May; 102(5):926-33. PubMed ID: 21261791
[TBL] [Abstract][Full Text] [Related]
75. Signalling transduction events involved in agonist-induced PGE2/EP4 receptor externalization in cultured rat dorsal root ganglion neurons.
Ma W; St-Jacques B
Eur J Pain; 2018 May; 22(5):845-861. PubMed ID: 29336505
[TBL] [Abstract][Full Text] [Related]
76. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione.
Mahfoud R; Maresca M; Garmy N; Fantini J
Toxicol Appl Pharmacol; 2002 Jun; 181(3):209-18. PubMed ID: 12079430
[TBL] [Abstract][Full Text] [Related]
77. Celecoxib reduces Deoxynivalenol induced proliferation, inflammation and protein kinase C translocation via modulating downstream targets in mouse skin.
Mishra S; Srivastava S; Divakar A; Mandal P; Dewangan J; Chaturvedi S; Wahajuddin M; Kumar S; Tripathi A; Rath SK
Chem Biol Interact; 2020 Aug; 326():109128. PubMed ID: 32416088
[TBL] [Abstract][Full Text] [Related]
78. Regulation of liver regeneration by prostaglandin E
Mohamed YS; Abdelsalam RM; Attia AS; Abdel-Aziz MT; El-Tanbouly DM
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1437-1446. PubMed ID: 32162076
[TBL] [Abstract][Full Text] [Related]
79. EP2 Receptor Blockade Attenuates COX-2 Upregulation During Intestinal Inflammation.
Golden J; Illingworth L; Kavarian P; Escobar O; Delaplain P; Isani M; Wang J; Lim J; Bowling J; Bell B; Gayer CP; Grishin A; Ford HR
Shock; 2020 Sep; 54(3):394-401. PubMed ID: 31490357
[TBL] [Abstract][Full Text] [Related]
80. Patulin activates the NRF2 pathway by modulation of miR-144 expression in HEK293 cells.
Pillay Y; Ghazi T; Raghubeer S; Nagiah S; Chuturgoon AA
Mycotoxin Res; 2021 Feb; 37(1):97-103. PubMed ID: 33403569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
